Source: Annual Congress 2008 - Asthma: mechanisms and treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Omarjee, B. Tanguy, P. Schlossmacher (Saint Denis, Reunion). Use of IgE testing and lung function in diagnosing severe asthma. Eur Respir J 2008; 32: Suppl. 52, 3755

Member's Comments

No comment yet.

Related content which might interest you: Use of an electronic wheeze detection tool to monitor development of wheeze during mannitol inhalational bronchial challenge for the diagnosis and management of asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Relevance of measurement of serum periostin for diagnosing bronchial asthma and estimating its lung function abnormalities Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Atopy, lung function and bronchial responsiveness in former paediatric asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 450s Year: 2005 Clinical relevance of small airways assessment by lung function tests in asthma Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation Source: Eur Respir Rev 2015; 24: 204-215 Year: 2015 Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Clinical use of induced sputum in the management of asthma. A noninvasive measurements of airway Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007 A proposal for standardization of the bronchial biopsy assessment in severe asthma Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Improvement in symptoms, wheezing and pulmonary function tests of asthmatic patients due to application of GINA in their treatment Source: Eur Respir J 2006; 28: Suppl. 50, 842s Year: 2006 Diagnostic value of specific nasal provocation in the diagnosis of allergic rhinitis in mild persistent asthma cases Source: Eur Respir J 2002; 20: Suppl. 38, 218s Year: 2002 Role of the lung volume measurement in the diagnosis of obstructive diseases in patients with restrictive ventilatory impairment Source: International Congress 2014 – Alterations of exercise and lung function in different diseases Year: 2014 Monitoring of pediatric asthma by symptoms and lung function versus symptoms, lung function and exhaled NO Source: Annual Congress 2004 - Monitoring childhood asthma Year: 2004 COPD: problems in diagnosis and measurement Source: Eur Respir J 2003; 21: 4S-12S Year: 2003 Application of impulse oscillometry and bronchial dilation test for analysis in patients with asthma and chronic obstructive pulmonary disease Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Determination of value the biomarkers of an inflammation at atopic asthma exacerbation caused by respiratory infection Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020